IVAN ROSAS to Indoles
This is a "connection" page, showing publications IVAN ROSAS has written about Indoles.
Connection Strength
1.316
-
Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2016 Jan 15; 193(2):112-3.
Score: 0.462
-
Update in diffuse parenchymal lung disease, 2013. Am J Respir Crit Care Med. 2015 Feb 01; 191(3):270-4.
Score: 0.433
-
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open Respir Res. 2025 Apr 10; 12(1).
Score: 0.219
-
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases. Respir Res. 2021 Mar 16; 22(1):84.
Score: 0.165
-
Glycogen synthase kinase 3-? inhibition induces lymphangiogenesis through ?-catenin-dependent and mTOR-independent pathways. PLoS One. 2019; 14(4):e0213831.
Score: 0.036